Summary
AI4MedImaging is developing a disruptive clinical software - AI4CMR.Plus - for fully automated assessment of heart function and structure based on Cardiac Magnetic Resonance (CMR), with the potential to disrupt the current state of art of cardiovascular disease (CVD). By simplifying, accelerating, and enhancing CMR assessment, AI4CMR.Plus is the long-sought key to unlock the full potential of magnetic resonance as routine and gold-standard heart imaging tool, towards a new era of high-precision CVD diagnosis. To sooner-than later gain visibility, market traction, and consolidate our value chain, we have launched an MVP version of our software - AI4CMR - to the EU market, early this year. With EIC support, we now aim at accelerating AI4CMR.Plus development and preparing its market launch for 2025. Commercial exploitation of AI4CMR.Plus will prompt a steady company growth, strengthen the EU digital sovereignty and, importantly, have life-changing impact to millions threatened by CVD.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/190149120 |
| Start date: | 01-09-2022 |
| End date: | 28-02-2025 |
| Total budget - Public funding: | 2 529 988,75 Euro - 1 753 842,00 Euro |
Cordis data
Original description
AI4MedImaging is developing a disruptive clinical software - AI4CMR.Plus - for fully automated assessment of heart function and structure based on Cardiac Magnetic Resonance (CMR), with the potential to disrupt the current state of art of cardiovascular disease (CVD). By simplifying, accelerating, and enhancing CMR assessment, AI4CMR.Plus is the long-sought key to unlock the full potential of magnetic resonance as routine and gold-standard heart imaging tool, towards a new era of high-precision CVD diagnosis. To sooner-than later gain visibility, market traction, and consolidate our value chain, we have launched an MVP version of our software - AI4CMR - to the EU market, early this year. With EIC support, we now aim at accelerating AI4CMR.Plus development and preparing its market launch for 2025. Commercial exploitation of AI4CMR.Plus will prompt a steady company growth, strengthen the EU digital sovereignty and, importantly, have life-changing impact to millions threatened by CVD.Status
SIGNEDCall topic
HORIZON-EIC-2022-ACCELERATOROPEN-01Update Date
09-02-2023
Geographical location(s)
